Flexibone Tablet
Flexibone Tablet, licence 80140970: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Viva Pharmaceutical Inc.
- NPN or DIN-HM
- 80140970
- Status
- Active licence
- Licence date
- 15 May 2025
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine B6: up to 20 mg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 2 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Vitamine D: up to 10 µg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 5 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- À vérifier
Vitamine B6: up to 20 mg a day according to the dosing instructions published by Health Canada, above the limite de sécurité from EFSAEuropean Food Safety Authority. for adults (12 mg a day). Le repère de l'EFSA porte sur l'apport total d'une journée, alimentation et compléments.
limite supérieure de sécurité (UL). EFSA, Overview on Tolerable Upper Intake Levels (version 11, August 2025), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Vitamine B6 Source : Pyridoxine | 10.0 mg | 20,000 µg |
| Calcium Source : Malate de dicalcium | 151.0 mg | 302,000 µg |
| Manganèse Source : Sulfate de manganèse (II) | 1.5 mg | 3,000 µg |
| Phosphore | 50.0 mg | 100,000 µg |
| Magnésium Source : Malate de magnésium | 100.0 mg | 200,000 µg |
| Bore Source : Boron hydrolyzed vegetable protein (HVP) chelate | 0.35 mg | Not calculated |
| Vitamine D Source : Cholécalciférol | 5.0 microgram | 10 µg |
| Vitamine D Source : Cholécalciférol | 200.0 UI | 10 µg |
| Vitamine K2 Source : Ménaquinone 7 | 50.0 microgram | 100 µg |
| Zinc Source : Oxyde de zinc | 5.0 mg | 10,000 µg |
| Bêta-carotène Source : bêta-carotène | 300.0 microgram | Not calculated |
| Bêta-carotène Source : bêta-carotène | 500.0 UI | Not calculated |
| Vitamine C Source : Ascorbate de calcium | 50.0 mg | 100,000 µg |
Non-medicinal ingredients
Hypromellose, Cellulose microcristalline, Cellulose microcrystalline silicifiée, Croscarmellose de sodium, Poly(alcool vinylique), Poly(éthylène glycol), Stéarate de magnésium, Dioxyde de silicium, Talc, Dioxyde de titane
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19.0 ans | 1.0 Comprimé | 2.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Contributes to maintaining general health. Helps in connective tissue formation. Helps in the development and maintenance of bones/(and) teeth. Helps in the development and maintenance of bones/cartilage/teeth/(and) gums. Helps maintain/support bone health. Helps to build strong bones/(and) teeth. Helps to form red blood cells. Multi-vitamin and multi-mineral supplement. Provitamin A/Source of vitamin A to help in the development and maintenance of bones/(and) teeth. Source of vitamin(s)/mineral(s)/vitamin(s) and mineral(s), a factor/factors in the maintenance of good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80140970
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.